RMR Wealth Builders’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
Other funds holding REGN
RMR Wealth Builders's REGN Position: Q3 2026 in Review
RMR Wealth Builders increased its Regeneron Pharmaceuticals (REGN) stake by 12% in Q3 2026, buying an estimated $468K and bringing the position to 5,958 shares worth $4.52M. The position accounts for 0.26% of the portfolio, ranked #60.
RMR Wealth Builders first reported a position in REGN in Q4 2020 and has held it in 9 quarters since. 1,242 funds tracked by Wall St. Rank hold REGN as of Q3 2026.
- RMR Wealth Builders held 5,958 shares of Regeneron Pharmaceuticals worth $4.52M as of Q3 2026.
- RMR Wealth Builders bought 619 Regeneron Pharmaceuticals shares in Q3 2026, an estimated $468K.
- Regeneron Pharmaceuticals made up 0.26% of RMR Wealth Builders's portfolio in Q3 2026, its #60 holding.
- RMR Wealth Builders first reported a position in Regeneron Pharmaceuticals in Q4 2020 and has held it in 9 quarters since.
- 1,242 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q3 2026.
Based on RMR Wealth Builders's 13F filing for Q3 2026, filed 22 Oct 2026.